Maxim Group analyst, Jason Kolbert, Mesoblast (NASDAQ: MESO) announced that Teva has walked away from Revascor, returning 100% of the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE